Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Karl Hecker, Kelly Bethel, Myla Lai-Goldman, R. Bryan Riggsbee, and More


Rubicon Genomics has hired Karl Hecker as vice president of product development. Previously, he was a principal scientist at HTG Molecular Diagnostics. He has also held positions at Quidel, PerkinElmer, Invitrogen, and Transgenomic.

Cypher Genomics has formed a scientific advisory board to guide the development and implementation of its products. It has appointed Kelly Bethel, Michael Hultner, Myla Lai-Goldman, Arnold Levine, and Diego Miralles. Cypher's co-founder Nicholas Schork will chair the board.

Bethel is a practicing hematopathologist in the Scripps Clinic Medical Group and holds an adjunct appointment at the Scripps Research Institute. She is also the medical director of the Blood Bank at Scripps Clinic and Green Hospital.

Hultner is chief scientist for Lockheed Martin's Health and Life Sciences division where he manages a diverse portfolio of healthcare innovations, including big data analytics, population-scale genomics, and synthetic biology.

Lai-Goldman is CEO and co-founder of GeneCentric Diagnostics, which spun out from the University of North Carolina, Chapel Hill. She also spent more than 18 years at Laboratory Corporation of America, serving as executive vice president, chief medical officer, and chief scientific officer.

Levine is a cancer research scientist and discovered the p53 tumor suppressor protein in 1979. He established the Simons Center for Systems Biology at the Institute for Advanced Study in Princeton, New Jersey. Previously, he was president of Rockefeller University, and prior to that he was the Harry C. Wiess Professor in Life Sciences and former chairman of the department of molecular biology at Princeton University.

Miralles is global head of innovation at Janssen and leads a group focused on integrating emerging technologies and partnerships in areas including genomics and clinical trials. He is also management sponsor of Janssen Labs and site head of the Janssen West Coast Research Center, part of Janssen Research & Development.

Myriad Genetics announced that R. Bryan Riggsbee will be its new executive VP, CFO, and treasurer starting October 16. In the interim, Jim Evans will continue to serve as CFO.

Prior to joining Myriad, Riggsbee was senior VP of corporate finance at Laboratory Corporation of America. Before that, he held various positions at General Electric and worked in the audit division at KPMG.